The business of clinical trials is booming. Private equity has taken notice.

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry's more hidden niches: They are pouring billions into the business of clinical drug trials.

source https://www.news-medical.net/news/20221202/The-business-of-clinical-trials-is-booming-Private-equity-has-taken-notice.aspx

Comments

Post a Comment

Popular posts from this blog

High levels of memory killer cells correlate with better survival in melanoma patients

Our skin contains specialized long-lived killer cells that protect against intruders. Researchers at Karolinska Institutet in Sweden and the University of Copenhagen in Denmark have now identified how these cells are formed, and shown that high levels of memory killer cells in cancer tissue correlate with a better survival rate in people with melanoma. source https://www.news-medical.net/news/20230602/High-levels-of-memory-killer-cells-correlate-with-better-survival-in-melanoma-patients.aspx
Read more

Large language models enhance differential diagnosis, paving the way for AI-assisted medical decision-making

Study explores optimizing large language models (LLMs) for differential diagnosis (DDx), demonstrating their potential in assisting clinicians with accurate disease diagnosis using real-world medical cases. source https://www.news-medical.net/news/20231207/Large-language-models-enhance-differential-diagnosis-paving-the-way-for-AI-assisted-medical-decision-making.aspx
Read more